Summary
The aim of the present study is to evaluate a method of establishing model of rabbit liver VX2 tumor using percutaneous puncture inoculation of tumor fragment guided by ultrasonography. VX2 tumor fragments were implanted into the liver of 13 New Zealand white rabbits flushed by 1 mL normal saline through percutaneous puncture needle guided by ultrasonography. Conventional ultrasonography and contrast-enhanced ultrasonography (CEUS) were performed 14 days after inoculation, and then the rabbits were sacrificed and pathologically examined. The success rate of inoculation was 100%. The average size of liver VX2 tumor was 1.7 cm×1.3 cm, CEUS of VX2 liver tumors showed the “rapid wash-in and wash-out” vascular pattern. There were significant differences between VX2 tumors and liver parenchyma in quantitative parameters of A, k and A × k (P<0.05), which meant that VX2 liver tumors were characterized by more blood flow volume and faster blood velocity than liver parenchyma. Tumor fragment flushed by normal saline into the liver through a needle may be a promising method for the induction of a hepatic tumor. And CEUS can be used for accurately assessing angiogenesis and blood perfusion of VX2 tumors.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
He J, Gu D, Wu X, et al. Major causes of death among men and women in China. N Engl J Med, 2005,353(11):1124–1134
Kawano Y, Sasaki A, Kai S, et al. Short- and long-term outcomes after hepatic resection for hepatocellular carcinoma with concomitant esophageal varices in patients with cirrhosis. Ann Surg Oncol, 2008,15(6):1670–1676
Scartozzi M, Baroni GS, Faloppi L, et al. Transarterial chemo-embolization (TACE), with either lipiodol (traditional TACE) or drug-eluting microspheres (precision TACE, pTACE) in the treatment of hepatocellular carcinoma: efficacy and safety results from a large monoinstitutional analysis. J Exp Clin Cancer Res, 2010,29:164
Numata K, Fukuda H, Ohto M, et al. Evaluation of the therapeutic efficacy of high-intensity focused ultrasound ablation of hepatocellular carcinoma by three-dimensional sonography with a perflubutane-based contrast agent. Eur J Radiol, 2010,75(2):e67–75
Moroz P, Metcalf C, Gray BN. Histologic analysis of liver tissue following hepatic arterial infusion of ferromagnetic particles in a rabbit tumour model. Biometals. 2003,16(3):455–464
Georges E, Breitburd F, Jibard N, et al. Two Shope papillomavirus-associated VX2 carcinoma cell lines with different levels of keratinocyte differentiation and transplantability. J Virol, 1985,55(1):246–250
Li C, Wang W, Ding H, et al. Value of contrast-enhanced sonography in the diagnosis of peripheral intrahepatic cholangiocarcinoma. J Clin Ultrasound, 2011,39(8):447–453
Gupta T, Virmani S, Neidt TM, et al. MR tracking of iron-labeled glass radioembolization microspheres during transcatheter delivery to rabbit VX2 liver tumors: feasibility study. Radiology, 2008,249(3):845–854
Lee KH, Liapi E, Ventura VP, et al. Evaluation of different calibrated spherical polyvinyl alcohol microspheres in transcatheter arterial chemoembolization: VX2 tumor model in rabbit liver. J Vasc Interv Radiol, 2008,19(7):1065–1069
Sun JH, Zhang YL, Nie CH, et al. Considerations for two inoculation methods of rabbit hepatic tumors: Pathology and image features. Exp Ther Med, 2012,3(3):386–390
Liu YJ, Ren WD, Liu CG, et al. Contrast-enhanced ultrasonography of the rabbit VX2 tumor model: analysis of vascular pathology. Oncol Lett, 2012,4(4):685–690
Wu H, Patel RB, Zheng Y, et al. Differentiation of benign periablational enhancement from residual tumor following radio-frequency ablation using contrast-enhanced ultrasonography in a rat subcutaneous colon cancer model. Ultrasound Med Bio, 2012,38(3):433–453
Cabibbo G, Enea M, Attanasio M, et al. A meta-analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma. Hepatology, 2010,51(4):1274–1283
Sonoda A, Nitta N, Ohta S, et al. Controlled release and antitumor effect of pluronic F127 mixed with cisplatin in a rabbit model. Cardiovasc Intervent Radiol, 2010,33(1):135–142
Hänsler J, Neureiter D, Wasserburger M, et al. Percutaneous US-guided radiofrequency ablation with perfused needle applicators: improved survival with the VX2 tumor model in rabbits. Radiology, 2004,230(1):169–174
Virmani S, Rhee TK, Ryu RK, et al. Comparison of hypoxia-inducible factor-1alpha expression before and after transcatheter arterial embolization in rabbit VX2 liver tumors. J Vasc Interv Radiol, 2008,19(10):1483–1489
Wilson SR, Greenbaum LD, Goldberg BB. Contrast-enhanced ultrasound: what is the evidence and what are the obstacles? AJR Am J Roentgenol, 2009,193(1):55–60
Acknowledgments
Histopathological examinations were performed by the Department of Pathology at Tongji Hospital, Huazhong University of Science and Technology. The authors would like to acknowledge the Department of Pathology for providing these resources for this study.
Author information
Authors and Affiliations
Corresponding author
Additional information
Conflict of Interest Statement
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Yi, Hm., Cai, Bh., Ai, X. et al. Establishment of Rabbit Liver VX2 Tumor Model Using Percutaneous Puncture Inoculation of Tumor Fragment Guided and Evaluated by Ultrasonography. CURR MED SCI 39, 820–824 (2019). https://doi.org/10.1007/s11596-019-2111-6
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11596-019-2111-6